Bain Capital Life Sciences Fund L.P. 13D and 13G filings for Pharvaris N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-01-22 4:30 pm Sale | 2024-01-18 | 13G | Pharvaris N.V. PHVS | Bain Capital Life Sciences Fund L.P. | 1,967,093 3.800% | -918,173 (-31.82%) | Filing |
2023-06-23 4:34 pm Unchanged | 2023-06-21 | 13G | Pharvaris N.V. PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 7.100% | 0 (Unchanged) | Filing |
2021-02-19 4:30 pm Purchase | 2021-02-09 | 13G | Pharvaris N.V. PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 9.100% | 2,885,266 (New Position) | Filing |